Free Newsletter
Studies ponder powers of a plant derivative
A biochemist at Rutger's Biotechnology Center says that the plant derivative Aframomum melegueta may include the most powerful anti-inflammatory known. Scientist Ilya Raskin was attracted to the rare derivative, which grows in West Africa, during her studies of plant-derived therapeutics. Aframomum figures into a number of home remedies in Africa and its absence in the diet of zoo gorillas is considered a possible cause of various diseases. One species of the plant has also been shown to work against MRSA. Phytomedics has licensed Aframomum for cosmetic purposes and Interleukin Genetics has been conducting clinical trials of the material to inhibit cytokine modulators, a component of the immune system.
- check out the article from The Washington Post on Aframomum
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: